News
BioCardia, Inc. has completed source data verification and finalized primary outcomes data for its Phase 3 CardiAMP HF study, which tests an autologous cell therapy for treating ischemic heart ...
GARDEN GROVE, Calif., July 14, 2025 (SEND2PRESS NEWSWIRE) — (IR), a premier technology provider delivering data-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback